Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8613908 | 0.77 | LMNA (0.40) | LMNACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL11445127 | 0.74 | LMNA (0.33) | LMNATSHRCYP2C19 | |
| SCHEMBL11884355 | 0.72 | LMNA (0.36) | LMNACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL15286219 | 0.72 | LMNA (0.36) | LMNACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL29021081 | 0.67 | LMNA (0.36) | LMNACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL11881407 | 0.67 | LMNA (0.36) | LMNACHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL7769672 | 0.65 | — | — | |
| SCHEMBL22556151 | 0.65 | LMNA (0.37) | LMNACHRM2CHRM4CHRM5CHRM1 | |
| Chloral Hydrate SCHEMBL28464822 | 0.65 | LMNA (0.60) | LMNATSHRCYP2C19 | |
| SCHEMBL11881390 | 0.64 | CYP1A2 (0.40) | LMNACHRM2CHRM4CHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115611867-B | (1, 1-Trichloro-2) carbamate derivative and preparation method and application thereof | 中南大学 | 2024-04-30 | — | — | CN | disclosed |
| CN-115611867-A | (1, 1-trichloro-2) carbamate derivatives, and preparation method and application thereof | 中南大学 | 2023-01-17 | — | — | CN | disclosed |
| CN-111606891-B | (1,1,1-trichloro-2) carbamate derivative and preparation method and application thereof | 中南大学 | 2023-01-17 | — | — | CN | disclosed |
| CN-111606891-A | (1,1, 1-trichloro-2) carbamate derivative and preparation method and application thereof | 中南大学 | 2020-09-01 | — | — | CN | disclosed |
| EP-1530582-A4 | DIAGNOSIS OF KIDNEY DAMAGE AND PROTECTION AGAINST SAME | UNIV OHIO (US) | 2008-08-20 | — | — | EP | disclosed |
| EP-1530582-A2 | DIAGNOSIS OF KIDNEY DAMAGE AND PROTECTION AGAINST SAME | Ohio University (US) | 2005-05-18 | — | — | EP | disclosed |
| WO-2004013289-A9 | DIAGNOSIS OF KIDNEY DAMAGE AND PROTECTION AGAINST SAME | UNIV OHIO (US) | 2004-08-12 | — | — | WO | disclosed |
| WO-2004013289-A2 | DIAGNOSIS OF KIDNEY DAMAGE AND PROTECTION AGAINST SAME | OHIO UNIVERSITY (US) | 2004-02-12 | — | — | WO | disclosed |
| EP-1360501-A2 | METHOD OF IDENTIFYING CONFORMATION-SENSITIVE BINDING PEPTIDES AND USES THEREOF | Karo Bio USA, Inc. (US) | 2003-11-12 | — | — | EP | disclosed |
| WO-2002004956-A9 | METHOD OF IDENTIFYING CONFORMATION-SENSITIVE BINDING PEPTIDES AND USES THEREOF | KARO BIO USA INC (US) | 2002-10-10 | — | — | WO | disclosed |
| WO-2002004956-A2 | METHOD OF IDENTIFYING CONFORMATION-SENSITIVE BINDING PEPTIDES AND USES THEREOF | KARO BIO USA, INC. (US) | 2002-01-17 | — | — | WO | disclosed |
| EP-1073891-A2 | METHOD OF PREDICITING RECEPTOR MODULATING ACTIVITY | Karo Bio USA, Inc. (US) | 2001-02-07 | — | — | EP | disclosed |
| EP-1002235-A1 | METHOD OF IDENTIFYING AND DEVELOPING DRUG LEADS | Novalon Pharmaceutical Corporation (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999054728-A2 | METHOD OF PREDICTING RECEPTOR MODULATING ACTIVITY | KARO BIO USA, INC. (US) | 1999-10-28 | — | — | WO | disclosed |
| EP-0937253-A1 | IDENTIFICATION OF DRUGS USING COMPLEMENTARY COMBINATORIAL LIBRARIES | Novalon Pharmaceutical Corporation (US) | 1999-08-25 | — | — | EP | disclosed |
| WO-1999006839-A1 | METHOD OF IDENTIFYING AND DEVELOPING DRUG LEADS | NOVALON PHARMACEUTICAL CORPORATION (US) | 1999-02-11 | — | — | WO | disclosed |
| WO-1998019162-A9 | IDENTIFICATION OF DRUGS USING COMPLEMENTARY COMBINATORIAL LIBRARIES | — | 1998-07-09 | — | — | WO | disclosed |
| WO-1998019162-A1 | IDENTIFICATION OF DRUGS USING COMPLEMENTARY COMBINATORIAL LIBRARIES | NOVALON PHARMACEUTICAL CORPORATION (US) | 1998-05-07 | — | — | WO | disclosed |